IGF-1 LR3, also known as Long-Arg3-IGF-I, is a synthetic peptide similar to Insulin-like Growth Factor 1 (IGF-1)
Typical criteria: BMI 30 (or 27 with hypertension, type 2 diabetes, sleep apnea, etc.) 3-6 months documented lifestyle efforts (diet and exercise in your medical record) No concurrent GLP-1 use (can't take Ozempic, Wegovy at same time) Step therapy: Some plans require trying other meds first Renewal: Must show 5% weight loss to continue coverage For complete documentation checklists and PA preparation: Zepbound Prior Authorization Guide denied approved Honest Care helps patients fight back: Evidence-backed appeal letters plus personalized guidance to appeal with confidence
Common Side Effects and Considerations Common side effects include mild-to-moderate gastrointestinal symptoms
Marketing Claims AOD9604 has gained massive attention in the fitness and wellness industry, often marketed as a fat-burning peptide that can melt away stubborn body fat without requiring significant lifestyle changes
Supporting the gut at this level can lead to improvements that extend throughout the entire body
BPC-157's angiogenic properties and growth factor modulation may support healthier tissue adaptation during this process